Tumors: Certain tumors metastasize in the spine
Not losing weight on Zepbound (tirzepatide) While a majority of people on tirzepatide lost weight in clinical trials, a small group of people failed to lose much weight on the medication
RCD subroutines in erythrocytes: are they limited to just eryptosis and necroptosis
Cardiologists also prescribe semaglutide in clinical practice, particularly for patients with established heart disease or diabetes, since GLP-1 agonists have demonstrated cardiovascular benefits in major trials
Consistent Monitoring: Regular check-ups with your doctor are essential for progress tracking, managing side effects, and adjusting your treatment plan
We need strategies to ensure broader, more equitable access so that these medications can be a scalable solution for obesity treatment. Hwang and colleagues used the Diabetes, Obesity, Cardiovascular Disease Microsimulation model to estimate the development of obesity-related conditions, quality of life and health costs for adults with overweight plus one weight-related comorbidity or obesity participating in lifestyle intervention or receiving an obesity drug plus lifestyle intervention
